MLICM
TIL icon

Metropolitan Life Insurance Company (MetLife)’s Instil Bio TIL Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-190
Closed -$18.4K – 2367
2022
Q3 		$18.4K Hold
190
– – ﹤0.01% 2066
2022
Q2 		$17.6K Hold
190
– – ﹤0.01% 2103
2022
Q1 		$40.9K Sell
190
-566
-75% -$132K ﹤0.01% 1711
2021
Q4 		$259K Buy
756
+440
+139% +$170K ﹤0.01% 1838
2021
Q3 		$113K Sell
316
-5
-2% -$1.87K ﹤0.01% 2463
2021
Q2 		$124K Buy
+321
New +$119K ﹤0.01% 2481

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s TIL Position: Q4 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Instil Bio (TIL) in Q4 2022, closing a stake of 190 shares — an estimated $18.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TIL in Q2 2021 and held it in 6 quarters. The position peaked at $259K in Q4 2021. 78 funds tracked by Wall St. Rank hold TIL as of Q4 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Instil Bio position as of Q4 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 190 Instil Bio shares in Q4 2022, an estimated $18.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Instil Bio in Q2 2021 and held it in 6 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Instil Bio position peaked at $259K in Q4 2021.
  • 78 funds tracked by Wall St. Rank held Instil Bio as of Q4 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2022, filed 15 Feb 2023.